{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PF06700841", "query": { "intervention": "PF06700841" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 17, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PF06700841&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T10:58:47.133Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03850483", "title": "Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "PF-06700841", "type": "DRUG" }, { "name": "Vehicle (Placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 344, "start_date": "2019-04-08", "completion_date": "2021-04-20", "has_results": true, "last_update_posted_date": "2022-06-29", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 38, "location_summary": "Scottsdale, Arizona • Hot Springs, Arkansas • Anaheim, California + 31 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03850483" }, { "nct_id": "NCT02958865", "title": "Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "PF-06651600 or Placebo", "type": "DRUG" }, { "name": "PF-06700841 or Placebo", "type": "DRUG" }, { "name": "PF-06700841", "type": "DRUG" }, { "name": "PF-06651600", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 319, "start_date": "2017-02-03", "completion_date": "2021-05-10", "has_results": true, "last_update_posted_date": "2022-07-21", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 60, "location_summary": "Dothan, Alabama • Long Beach, California • Los Angeles, California + 26 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02958865" }, { "nct_id": "NCT04090047", "title": "A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Heathy Participants" ], "interventions": [ { "name": "PF-06700841", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2019-09-24", "completion_date": "2019-12-19", "has_results": false, "last_update_posted_date": "2020-01-30", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04090047" }, { "nct_id": "NCT02310750", "title": "A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "PF-06700841 oral solution/suspension", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "PF-06700841 tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 96, "start_date": "2014-11", "completion_date": "2016-02", "has_results": true, "last_update_posted_date": "2017-03-08", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 1, "location_summary": "Anaheim, California", "locations": [ { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02310750" }, { "nct_id": "NCT03395184", "title": "Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Crohn's Disease" ], "interventions": [ { "name": "PF-06651600 Placebo", "type": "DRUG" }, { "name": "PF-06651600", "type": "DRUG" }, { "name": "Placebo PF-06700841", "type": "DRUG" }, { "name": "PF-06700841", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 244, "start_date": "2018-02-02", "completion_date": "2023-10-19", "has_results": true, "last_update_posted_date": "2024-10-30", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 57, "location_summary": "Dothan, Alabama • Beverly Hills, California • Los Angeles, California + 25 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03395184" }, { "nct_id": "NCT05437263", "title": "A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dermatomyositis" ], "interventions": [ { "name": "Brepocitinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Priovant Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 241, "start_date": "2022-10-31", "completion_date": "2026-07", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 39, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Irvine, California + 33 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Irvine", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05437263" }, { "nct_id": "NCT04580797", "title": "Clinical Study to Evaluate Pharmacokinetics and Safety of PF-06700841 After Single and Multiple Oral Doses as Modified Release Formulations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "PF-06700841 IR", "type": "DRUG" }, { "name": "PF-06700841 MR1", "type": "DRUG" }, { "name": "PF-06700841 MR2", "type": "DRUG" }, { "name": "PF-06700841 MR3", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 36, "start_date": "2020-10-02", "completion_date": "2021-01-11", "has_results": false, "last_update_posted_date": "2021-03-08", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 2, "location_summary": "Coral Gables, Florida • Miami, Florida", "locations": [ { "city": "Coral Gables", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04580797" }, { "nct_id": "NCT03903822", "title": "Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "PF-06700841", "type": "DRUG" }, { "name": "Vehicle (Placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 292, "start_date": "2019-05-13", "completion_date": "2020-05-07", "has_results": true, "last_update_posted_date": "2021-03-29", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Encinitas, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03903822" }, { "nct_id": "NCT03845517", "title": "A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "PF-06700841 15 mg", "type": "DRUG" }, { "name": "PF-06700841 30 mg", "type": "DRUG" }, { "name": "PF-06700841 45 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 350, "start_date": "2019-04-18", "completion_date": "2023-10-05", "has_results": true, "last_update_posted_date": "2024-09-05", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Fullerton, California • La Palma, California + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT03845517" }, { "nct_id": "NCT04267250", "title": "Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Female Volunteers" ], "interventions": [ { "name": "PF-06700841", "type": "DRUG" }, { "name": "Ethinyl estradiol (EE) and levonorgestrel (LN)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "18 Years to 60 Years · Female only" }, "enrollment_count": 18, "start_date": "2020-08-24", "completion_date": "2020-11-06", "has_results": false, "last_update_posted_date": "2020-11-13", "last_synced_at": "2026-09-11T10:58:47.133Z", "location_count": 2, "location_summary": "Coral Gables, Florida • Miami, Florida", "locations": [ { "city": "Coral Gables", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04267250" } ] }